Analysis of original bis-arylazaazkanes derivatives compliance with the calculated pharmacophoric models of biaromatic ligands of cardioprotective drugs biotargets
Eight important biotargets of biaromatic cardioprotective drugs were selected in this work: calcium Cav1.2-channel, sodium Nav1.5-channel, potassium hERG-channel and Kv1.5-channel, HCN-channel, β1-adrenergic receptor, ryanodine RyR2-receptor and σ1-receptor. Biaromatic ligands databases were collect...
Saved in:
Main Authors: | G. V. Mokrov, A. S. Pantileev, T. Yu. Vorobieva, V. E. Biryukova, S. A. Kryzhanovskii, V. L. Dorofeev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC “Publisher OKI”
2024-06-01
|
Series: | Фармакокинетика и Фармакодинамика |
Subjects: | |
Online Access: | https://www.pharmacokinetica.ru/jour/article/view/410 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of the antiarrhythmic activity of linear alkoxyphenylazalkanes in the model of reperfusion arrythmias in rats
by: V. V. Barchukov, et al.
Published: (2023-07-01) -
Сardioprotective agents with biaromatic structure. Part 6. Beta blockers
by: G. V. Mokrov
Published: (2023-11-01) -
Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers
by: G. V. Mokrov
Published: (2022-07-01) -
Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats
by: G. B. Kolyvanov, et al.
Published: (2022-01-01) -
Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers
by: G. V. Mokrov
Published: (2022-02-01)